⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AUPH News
Aurinia Pharmaceuticals Inc
Form 8-K
sec.gov
AUPH
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
businesswire.com
AUPH
Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026
businesswire.com
AUPH
Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
prnewswire.com
AUPH
PTC
AuditBoard Appoints Hugo Doetsch as Chief Financial Officer
prnewswire.com
AUPH
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress
businesswire.com
AUPH
Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025
businesswire.com
AUPH
Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS ® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025
businesswire.com
AUPH